Irritable Bowel Syndrome Treatment Market in Global Industry: Demands, Insights, Research and Forecast 2027
Research Reports
Mar 15, 2022
The constantly increasing economic burden of IBS affects work productivity and leads to an increase in healthcare costs. This, in turn, has raised awareness about the disorder, thus, favoring the expansion of the global market. In addition, the large-scale prevalence of anxiety and depression is anticipated to catalyze the growth of the irritable bowel syndrome treatment market over the assessment period.
According to Market Research Future (MRFR)’s new study, the global irritable bowel syndrome treatment market is projected to thrive at a CAGR of 7.58% during the forecast period.
The key players are continually investing in drug development for capitalizing on the rising patient pool. Furthermore, the collaborations among the key players are supposed to have a positive influence on the proliferation of the irritable bowel syndrome treatment market. On the flip side, stringent regulations framed by governments and limited patient satisfaction are predicted to hinder the proliferation of the market during the assessment period.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7044
Market Segmentation
The major types of IBS are IBS-D, IBS-M., and IBS-C. Out of these, the IBS-D type is the top segment in the global market and will retain its dominance all through the upcoming period. It will be valued at USD 1790.6 Mn by 2027, while garnering a growth rate of 8.31?tween 2020 and 2027.
The primary drug types available in the irritable bowel syndrome treatment industry include alosetron, linaclotide, lubiprostone, rifaximin, eluxadoline, and others.
Major industry end-users listed in the review study are research laboratories, clinics, hospitals, and others.
Regional Analysis
Americas prevails as the global market leader, given the mounting awareness among people about IBS, blossoming patient base, and the well-established healthcare industry. As a result, the American market can achieve a strong valuation of USD 1,416.2 Mn by the end of 2027, clocking in a growth rate of 8.69% all through the assessment period. High availability of quality and superior healthcare facilities across the US and Canada and the rapidly burgeoning geriatric populace further fosters the market demand within the region. The sharp rise in the cases prompts a higher demand for highly effective diagnostic tests and treatment options in the region.
The extensive market growth in APAC is the result of the rising prevalence of irritable bowel syndrome and the soaring need for effective treatment methods. Considering the aggravating scenario in the region, a number of non-profit organizations and government agencies are taking up initiatives to boost the awareness level with regard to the disorder. Technological advances with respect to treatment have facilitated emergence of advanced solutions in the market, which could translate into substantial profits in the years to come. The soaring number of hospitals, and the escalating demand for affordable yet efficient treatments in India, Singapore, Vietnam, and China add significant value to the APAC market.
Renowned Contenders
The important IBS treatment solutions and devices manufacturers covered in the MRFR review study include Synergy Pharmaceuticals Inc., Ardelyx Inc., Astellas Pharma, Inc., Lexicon Pharmaceuticals, Inc., Abbott, Valeant Pharmaceuticals International, Inc., Ironwood Pharmaceuticals, Allergan Inc., Mallinckrodt, Nestle Health Science, and many more.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/irritable-bowel-syndrome-treatment-market-7044
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact Information:
Market Research Future (part of Wantstats Research and Media Private Limited), 99 Hudson Street,5Th Floor, New York, New York 10013, United States of America +1 646 845 9312 Email: sales@marketresearchfuture.com
Tags:
PR-Wirein, Wire, Research Newswire, English